Christine Cserti-Gazdewich is a transfusion medicine specialist and consultant hematologist based at the University Health Network, where she is an associate medical director of the Blood Transfusion Laboratory and its cross-province client sites. Her chief interests in practice, leadership, and research are in immunohematology, hemovigilance, and complex compatibility/constrained-access scenarios.
Hemovigilance is an important activity in the licensed operation of blood transfusion laboratories. Serologic testing doesn’t stand alone, but is linked to a therapeutic dispensary with consequences. This session addresses how internal (and overall blood system) safety is met in the context of three layers: pre-release activities (limiting inappropriate use and assuring compatibility), relevant exercises around disturbances associated with blood products (using structured approaches to recognition and case formulation), and reporting duties after the fact (relating to what must be tracked, who it must be shared with, and why).
1. Relate the role of the transfusion laboratory in reaction avoidance, relating to resource stewardship and compatibility testing.
2. Restate the policy & procedure structures enabling bedside reaction identification, reporting, appropriate testing, and management.
3. Select the laboratory’s situational reporting mandates (internally to the hospital transfusion committee, and externally to manufacturers & regulators)
Medical Expert (the integrating role)